Review ArticleSarcoidosis-Like Reactions Induced by Checkpoint Inhibitors
Under an Elsevier user license
open archive
Keywords
Checkpoint inhibitors
Immune-related adverse events
Sarcoidosis-like reactions
Cited by (0)
Disclosure: Dr. Gkiozos has received personal fees from Boehringer Ingelheim, Bristol-Myers Squibb, and Roche. Dr. Kopitopoulou has received personal fees from Bristol-Myers Squibb. Dr. Judson has received grants from Mallinckrodt Pharmaceuticals and Novartis; and he has received personal fees from Biogen.
Dr. Syrigos has received grants from Boeringer Ingelheim, Bristol-Myers Squibb, Merck Sarono, and Roche; and has received personal fees from Roche, Bayer, Astra Zeneca, and MSD. The remaining authors declare no conflict of interest.
© 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc.